Weide & Miller Outpacing 2019 Patent Grants
Weide & Miller successfully obtained 57 patents for its clients in the first half of 2020, outpacing the number of patents the firm obtained for clients in 2019.
Weide & Miller Obtains Favorable Settlement for Lightside Technologies
Weide & Miller filed a suit in the U.S. District Court for the Central District of California on behalf of its client Lightside Technologies against Westinghouse Electronics for infringement of Lightside’s patent portfolio covering Multi-Format Audio/Visual Production Systems with Frame-Rate Conversion. [...]
Weide & Miller Successfully Invalidate Patent in Ex Parte Reexamination Proceeding
On January 10, 2020, the U.S. Patent and Trademark Office Patent Trial and Appeal Board affirmed the Examiner’s decision in the Ex Parte Reexamination of U.S. Patent No. 9,313,456. Attorneys at Weide & Miller submitted the Request for Ex Parte Reexamination in [...]
Issuance of 101 U.S. Utility and Design Patents in 2019
2019 was an extremely successful year, with Weide & Miller obtaining the issuance of 101 U.S. utility and design patents for its clients.
Complete Reversal at the Patent Trial and Appeal Board
Weide & Miller obtains a complete reversal at the Patent Trial and Appeal Board. Weide & Miller had appealed the examiner’s rejection of all claims in U.S. Application Serial No. 15/057,289, directed to a closed-loop medication monitoring and feedback system. The examiner had [...]
March 2019: Copyright Registration as a Prerequisite to a Lawsuit
On March 4, 2019, the Supreme Court resolved an issue on which the various federal circuit courts were split: can a copyright plaintiff bring a lawsuit once they have filed an application for registration with the Copyright Office, or must they wait until [...]
CAN MY INVENTION BE PATENTED?
UNDERSTANDING 35 U.S.C. § 101 AND THE ALICE DECISION Overview Section 101 sets forth the type of inventions which are entitled to be patented (assuming they meet the other requirements for patentability, such as novelty (under Section 102) and non-obviousness (under Section 103)). [...]
January 2019: On Sale Bar
In the case of Helsinn Healthcare S.A., v. Teva Pharmaceuticals USA, Inc., et al., the U.S. Supreme Court ruled that changes to Section 102 of the America Invents Act did not change the meaning of the “on-sale” bar as it was previously interpreted. [...]
January 2019: USPTO Subject Matter Eligibility Guidance
The USPTO has issued modified subject-matter eligibility (“Section 101”) guidance. The new guidance recognizes the need for increased clarity and consistency in how Section 101 is applied. Under current Section 101 case law, an invention may not be patented if it is [...]
January 2019: Firm News
Weide & Miller issued 88 patents in 2018, leading Nevada based firms.
